Mr. Chair, I would like to make a proposal. With regard to the thalidomide study, in the interest of time, if the Health Department does not get back to us with the information that we need by April 10, it would seem appropriate to me that we propose to go forward with the study on May 9 and 11 and bring forward the department as our first witness.
We already have the answer to one of the questions. When the minister was here with regard to the opioids study, she said that there are 24 affected individuals. We have that on record. We can recall that record if you so wish, but there is no reason why Health Canada can't be our first witness for this study and why this cannot go forward on May 9 and 11. I would propose that we solidify those dates.